Amicus Therapeutics
FOLD • NASDAQ
Amicus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bradley L. Campbell, with a market cap of $4.5B.
Market Cap$4.5B
Employees517.0
CEOBradley L. Campbell
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Amicus Therapeutics FAQ
Common questions about Amicus Therapeutics
Amicus Therapeutics is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $161.2M.
Amicus Therapeutics has approximately 517 employees.